In his keynote presentation at D4 in Basel last October, Philippe Marc, Global Head Integrated Data Sciences at Novartis, set […]
Current treatments for Parkinson’s disease are mainly dopaminergic drugs. However, these are limited by several side effects and can only […]
Real-world evidence can be used to show that a drug or medical device is safe and effective. The FDA has […]
Here we summarise a recent review article, published in Neuroimaging Clinics, that explored the additive value of artificial intelligence (AI) […]
Researchers from John Hopkins have developed a star-shaped device that can latch onto intestinal mucosa and release drugs into the […]
The National Institutes of Health (NIH) have funded a five-year effort to use state-of-the-art artificial intelligence methods to study Alzheimer’s […]
Researchers have combined structural and functional magnetic resonance imaging (MRI) with machine learning (ML) techniques to aid in accurately identifying […]
A recent review, in Nature Reviews Neurology, has provided an overview of the promising compounds for clinical trials in individuals […]
A recent review, published in Pharmacological Reports, discusses the current efficacy of drug repurposing against COVID-19. The search The race […]
A recent Nature review, describes the latest developments in the use of machine learning approaches to interrogate datasets in neurodegenerative […]
